Developing and accelerating novel diagnostics and therapies for Alzheimer’s disease. C2N new PrecivityAD™ blood test for Alzheimers disease. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer disease.